Global Drug Eruptions Treatment Market to reach US$ 7.1 billion by 2033, Antihistamines to account for 41% of all Treatments | FMI Study

The global drug eruptions market is estimated to be valued US$ 3.89 billion in fiscal year 2023, compared to US$ 3.66 billion in fiscal year 2022. The global market is anticipated to increase steadily from 2023 to 2033 at a 6.2% CAGR, reaching US$ 7.1 billion by the end of that year. Skin sensitivity to …

The Global Eosinophilic Granulomatosis with Polyangiitis Treatment Market Is Expected to Register Growth at 5.2% CAGR through 2033 | FMI Study

In 2023, Eosinophilic Granulomatosis with Polyangiitis Treatment Market is expected to reach a value of US$ 173.8 million at a CAGR of 5.2%. Healthcare technology advancements are expected to drive the market to US$ 288.5 million by 2033. The growing occurrences of churg strauss syndrome and other allergic reactions and asthma, rising geriatric population, and …

Promising Results from Gene Delivery and Enzyme Replacement Therapies to Revolutionize the USA Fucosidosis Therapeutics Market | FMI Predicts 25% of Revenue to Come from North America

According to Future Market Insights, North America is anticipated to hold around 25% share in the global fucosidosis therapeutics market during the forecast period. Within North America, the USA fucosidosis therapeutics market is predicted to exert a domineering influence throughout the projected period. Advanced therapies such as gene therapy and enzyme replacement therapy (ERT) are …

Eisenmenger Complex Management Market to reach US$ 12.9 billion in 2033, Endothelin Receptors to account for 48.1% of all Drugs | FMI Study

The global Eisenmenger complex management market is expected to surpass an impressive valuation of US$ 7.7 billion in 2023 and is projected to reach US$ 12.9 billion by 2033, growing at a CAGR of 5.3%. Generally, the treatment includes relieving the symptoms and associated co-morbidities. Medications such as calcium channel blockers, antiarrhythmic agents, and blood …

Biopsy Device Market reaching a valuation of US$ 3.3 billion by the end of 2033 | FMI

Over the 10-year forecast period 2021-2031, the global biopsy device market is estimated to witness a moderate yet promising CAGR of 5.2%, according to Future Market Insights. In a recently published report titled “Global Biopsy Device Market: Global Industry Analysis and Opportunity Assessment, 2021–2031” Future Market Insights analyses the market for biopsy device and offers key insights factors …

Gamma Knife Market holds a valuation of US$ 343.1 million as of 2023

[309 Pages Report] FMI, in its research report, has covered the Gamma Knife market in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America Gamma Knife market, valued at US$ 46.3 Mn in 2014 will expand at a CAGR of 7.5% through 2025, reaching a valuation of over US$ 100 Mn …

Ophthalmic Lasers Market is projected to increase from a valuation of US$ 884.3 Mn in 2022 to US$ 1.3 Bn by 2030

[294 Pages Report] Technological advancements have deeply penetrated every facet of the healthcare industry, and the ophthalmic lasers market is no exception. Over the years, ophthalmic disorders such as diabetic retinopathy, refractive errors, glaucoma, cataract and age related macular degeneration (AMD) have surged exponentially. This has accelerated demand for advanced surgical procedures. The introduction of ophthalmic laser …

North America Vision Care Market is likely to secure a CAGR of 9.5% through 2032

Future Market Insights delivers key insights on the North America vision care market in a new publication titled “Vision Care Market: North America Industry Analysis and Opportunity Assessment, 2016 – 2026”. Vision care is a billion dollar market accounting for a substantial proportion of worldwide healthcare expenditure. In terms of revenue, the North America vision care market …

Prosthetic Heart Valve Market is projected to grow at a prolific CAGR of 11.4% between 2022 and 2032

According to Future Market Insights, an increasing prevalence of valvular heart disease (VHD) is expected to augment growth of the global prosthetic heart valve market during the forecast period. Regulatory approval for heart valves, integration of technological advancements, and increasing number of heart valve implantation procedures are other factors expected to influence revenue growth of the global …

Coronary Stents Market is projected to grow at a 5.1% CAGR from 2022 to 2032

According to the most recent Future Market Insights (FMI) report, the demand for portable and coronary stents market will increase significantly over the next few years. The demand for interventional cardiology care is being fuelled by the rising prevalence of coronary artery disease. Angioplasty is the first choice of treatment for patients with long-term CAD. Over the …